-
Pest control gets the CRISPR treatment Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-23
Precision genetic methods are enabling more efficient, environmentally friendly pest control methods for agricultural use as well as stopping the spread of disease.
-
Immunogenic amines on lipid nanoparticles Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-10-23 Preeti Sharma, Dor Breier, Dan Peer
-
Improving the catalytic performance of carbonyl reductase based on the functional loops engineering Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-22 Tao-Shun Zhou, Xiang-Yang Li, Xiao-Jian Zhang, Xue Cai, Zhi-Qiang Liu, Yu-Guo Zheng
-
Elevated endoplasmic reticulum pH is associated with high growth and bisAb aggregation in CHO cells Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-22 Kevin S. McFarland, Kaitlin Hegadorn, Michael J. Betenbaugh, Michael W. Handlogten
Chinese hamster ovary (CHO) bioprocesses, the dominant platform for therapeutic protein production, are increasingly used to produce complex multispecific proteins. Product quantity and quality are affected by intracellular conditions, but these are challenging to measure and often overlooked during process optimization studies. pH is known to impact quality attributes like protein aggregation across
-
Downregulating human leucocyte antigens on mesenchymal stromal cells by epigenetically repressing a β2-microglobulin super-enhancer Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-10-21 Fei Wang, Ran Li, Jing Yi Xu, Xiaoxia Bai, Ying Wang, Xu Ri Chen, Chen Pan, Shen Chen, Ke Zhou, Boon Chin Heng, Xuewei Wu, Wei Guo, Zhe Song, Shu Cheng Jin, Jing Zhou, Xiao Hui Zou, Hong Wei Ouyang, Hua Liu
-
Droplet Hi-C enables scalable, single-cell profiling of chromatin architecture in heterogeneous tissues Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-18 Lei Chang, Yang Xie, Brett Taylor, Zhaoning Wang, Jiachen Sun, Ethan J. Armand, Shreya Mishra, Jie Xu, Melodi Tastemel, Audrey Lie, Zane A. Gibbs, Hannah S. Indralingam, Tuyet M. Tan, Rafael Bejar, Clark C. Chen, Frank B. Furnari, Ming Hu, Bing Ren
-
-
Adjustment of the main biosynthesis modules to enhance the production of l‐homoserine in Escherichia coli W3110 Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-19 Kun Niu, Rui Zheng, Miao Zhang, Mao‐Qin Chen, Yi‐Ming Kong, Zhi‐Qiang Liu, Yu‐Guo Zheng
-
AI-based automated construction of high-precision Geobacillus thermoglucosidasius enzyme constraint model. Metab. Eng. (IF 6.8) Pub Date : 2024-10-18 Minghao Zhang,Haijiao Shi,Xiaohong Wang,Yanan Zhu,Zilong Li,Linna Tu,Yu Zheng,Menglei Xia,Weishan Wang,Min Wang
Geobacillus thermoglucosidasius NCIMB 11955 possesses advantages, such as high-temperature tolerance, rapid growth rate, and low contamination risk. Additionally, it features efficient gene editing tools, making it one of the most promising next-generation cell factories. However, as a non-model microorganism, a lack of metabolic information significantly hampers the construction of high-precision
-
Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-10-17 Zhen Xia, Qihan Jin, Zhilin Long, Yexuan He, Fuyi Liu, Chengfang Sun, Jinyang Liao, Chun Wang, Chentong Wang, Jian Zheng, Weixi Zhao, Tianxin Zhang, Jeremy N. Rich, Yongdeng Zhang, Longxing Cao, Qi Xie
-
Systemically injected oxygen within rapidly dissolving microbubbles improves the outcomes of severe hypoxaemia in swine Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-10-17 Julia Garcia Mancebo, Kristen Sack, Jay Hartford, Saffron Dominguez, Michelle Balcarcel-Monzon, Elizabeth Chartier, Tien Nguyen, Alexis R. Cole, Francesca Sperotto, David M. Harrild, Brian D. Polizzotti, Allen D. Everett, Alan B. Packard, Jason Dearling, Arthur G. Nedder, Simon Warfield, Edward Yang, Hart G. W. Lidov, John N. Kheir, Yifeng Peng
-
Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoprotein Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-16 Kai Chen, Hesong Han, Sheng Zhao, Bryant Xu, Boyan Yin, Atip Lawanprasert, Marena Trinidad, Benjamin W. Burgstone, Niren Murthy, Jennifer A. Doudna
-
Global profiling of protein complex dynamics with an experimental library of protein interaction markers Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-16 Christian Dörig, Cathy Marulli, Thomas Peskett, Norbert Volkmar, Lorenzo Pantolini, Gabriel Studer, Camilla Paleari, Fabian Frommelt, Torsten Schwede, Natalie de Souza, Yves Barral, Paola Picotti
-
Biotechnology and Bioengineering: Volume 121, Number 11, November 2024 Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-16
Click on the article title to read more.
-
Reshaping the substrate‐binding pocket of acyl‐ACP reductase to enhance the production of sustainable aviation fuel in Escherichia coli Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-16 Jiahu Han, Takuya Matsumoto, Ryosuke Yamada, Hiroyasu Ogino
To reduce carbon emissions and address environmental concerns, the aviation industry is exploring the use of sustainable aviation fuel (SAF) as an alternative to traditional fossil fuels. In this context, bio‐alkane is considered a potentially high‐value solution. The present study focuses on the enzymes acyl‐acyl carrier protein [ACP] reductase (AAR) and aldehyde‐deformylating oxygenase (ADO), which
-
Cover Image, Volume 121, Number 11, November 2024 Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-16 Jimmy Boman, Tjaša Marušič, Tina Vodopivec Seravalli, Janja Skok, Fredrik Pettersson, Kristina Šprinzar Nemec, Henrik Widmark, Rok Sekirnik
-
Transfer learning Bayesian optimization for competitor DNA molecule design for use in diagnostic assays Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-16 Ruby Sedgwick, John P. Goertz, Molly M. Stevens, Ruth Misener, Mark van der Wilk
-
A strategy to load, rethread and read protein sequences through a nanopore Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14 Iris Marchal
Understanding proteomic diversity at the molecular level is essential for advances in biology and medicine, but sequencing proteins in their full, native form remains challenging. A study in Nature by Motone et al. introduces a nanopore sequencing method that can read single, full-length protein molecules, enabling the detection of single amino acid substitutions and post-translational modifications
-
Niemann–Pick double win Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14
In one week, the US Food and Drug Administration approved two treatments for Niemann–Pick disease type C (NPC). One agent, Miplyffa (arimoclomol) from Zevra Therapeutics, is the first drug approved by FDA to treat neurologic symptoms associated with NPC, in combination with the enzyme inhibitor miglustat. The other is IntraBio’s Aqneursa (levacetylleucine), an oral modified amino acid (N-acetyl-l-leucine)
-
T cells Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14
Recent patents relating to the manufacture, preparation and use of T cells in treating cancer.
-
Cellular shuttles put mislocalized proteins in their right place Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14 Iris Marchal
The misplacement of proteins within a cell can cause various diseases, but no therapeutic intervention can precisely control protein location. Writing in Nature, Ng et al. describe targeted relocalization-activating molecules (TRAMs) that couple misplaced proteins to cellular shuttles, relocating them to their proper places. Ng et al. began by testing a TRAM previously used to bring together two proteins
-
Bispecific upstages Keytruda Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14
The new bispecific drug ivonescimab has outperformed Merck’s blockbuster PD-1 checkpoint inhibitor Keytruda (pembrolizumab) in a head-to-head clinical trial of non-small-cell lung cancer. The dual-action VEGF–PD-1 antibody nearly doubled progression-free survival over the PD-1 blocker, according to phase 3 data presented by Summit Therapeutics at the World Conference on Lung Cancer in San Diego in
-
Pan-KRAS destruction with a single PROTAC Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14 Iris Marchal
Most small-molecule drugs that target oncogenic Kirsten rat sarcoma virus (KRAS) mutants rely on interactions with variant-specific amino acid residues. However, a wide range of KRAS mutations are prevalent in human cancers, and undruggable variants pose a great challenge to the clinical treatment of KRAS-mutant tumors. In a paper published in Science, Popow et al. address this issue by designing a
-
From Bench to Podcast: Chloe Fishman Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14
Join us as Cláudia and Chloe touch bases on the advantages of this tool over existing methods, discuss the relevance of phage therapy to the fight against antimicrobial resistance and share their thoughts on the crucial role mentorship plays in empowering early career researchers. If you are interested in phage therapy and astrobiology, then this episode is for you!
-
Biotech news from around the world Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14
1. UNITED KINGDOM Merck opens a new research lab in London on the top floor of the Crick Institute in King’s Cross. As part of Merck’s growing presence in the UK, the lab will focus on preclinical development of neuroscience and immunology therapies. The new site builds on Merck’s $1.3 billion ten-story research center and UK headquarters, also in King’s Cross, scheduled to open in 2027.
-
Editor’s pick: Switch Therapeutics Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14
Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year. Switch Therapeutics is rethinking cell-type specificity, building precision RNAi therapeutics for the brain.
-
Five questions with Weixin Tang Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14 Michael Francisco
A chemist pioneering the discovery and engineering of CRISPR-derived gene-editing agents for medical adaptation talks about her scientific journey, the challenges of leading a lab and teaching undergraduates.
-
People Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14
Recent moves of note in and around the biotech and pharma industries.
-
Accessible training for academic clinicians and researchers to address the need for academic entrepreneurs Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14 Victoria Bartek, Daria Ferro, Flaura Winston, Mark Kessel
A short course in the fundamentals of academic entrepreneurship is a feasible way to train scientists and physicians from varied backgrounds and experience.
-
The European Innovation Council supports innovative portfolios in health biotech Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14 Iordanis Arzimanoglou
-
The global patent landscape of functional food innovation Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-14 Maima Matin, Dalibor Hrg, Olena Litvinova, Małgorzata Łysek-Gładysinska, Agnieszka Wierzbicka, Jarosław Olav Horbańczuk, Artur Jóźwik, Atanas G. Atanasov
-
Interpretable discovery of patterns in tabular data via spatially semantic topographic maps Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-10-15 Rui Yan, Md Tauhidual Islam, Lei Xing
-
Application and progress of 3D tumor models in breast cancer Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-15 Jiaojiao Xu, Wanxia Fang, Huanhuan Zhou, Ruiyuan Jiang, Zhanhong Chen, Xiaojia Wang
-
Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-15 Fang Ba, Yufei Zhang, Luyao Wang, Wan‐Qiu Liu, Jian Li
Synthetic BioBricks introduce novel capabilities to manipulate genetic information, direct transcription‐translation processes, and program cellular behaviors in living organisms. To maintain the stability and functionality of synthetic BioBricks, assembled DNA fragments should be mutually compatible without inducing negative effects such as metabolic burden or cellular toxicity in host cells. However
-
Growth-coupled production of L-isoleucine in Escherichia coli via metabolic engineering. Metab. Eng. (IF 6.8) Pub Date : 2024-10-14 Nan Lu,Minhua Wei,Xuejing Yang,Yingzi Li,Hao Sun,Qianyu Yan,Haibin Zhang,Jilong He,Jie Ma,Menglei Xia,Chenglin Zhang
L-isoleucine, an essential amino acid, is widely used in the pharmaceutical and food industries. However, the current production efficiency is insufficient to meet the increasing demands. In this study, we aimed to develop an efficient L-isoleucine-producing strain of Escherichia coli. First, accumulation of L-isoleucine was achieved by employing feedback-resistant enzymes. Next, a growth-coupled L-isoleucine
-
Biosynthesis of pterostilbene in Escherichia coli from resveratrol on macroporous adsorption resin using a two‐step substrate addition strategy Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-14 Bao Yingling, Wu Xueqin, Chen Xiaolong
Pterostilbene (PST), a 3’,5’‐O‐methylated derivative of resveratrol (RSV), is a potent natural antioxidant produced by some plants in trace amounts as defense compound. It exhibits various health‐promoting activities, such as anticancer, antiviral, and antimicrobial effects. Large‐scale biosynthesis of PST is crucial due to the challenges associated with extracting it from plants. This study aims to
-
PCR‐ and wash‐free detection of serum miRNA via signaling probe hybridization Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-14 Haruka Uno, Hiyori Takeuchi, Ishin Abe, Tomoko Yoshino, Tomoyuki Taguchi, Yuko Hirakawa, Tadashi Matsunaga, Tsuyoshi Tanaka
-
An antigen discovery pipeline integrates multi-omics data and informs immunotherapy Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-11
-
Model-directed generation of artificial CRISPR–Cas13a guide RNA sequences improves nucleic acid detection Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-11 Sreekar Mantena, Priya P. Pillai, Brittany A. Petros, Nicole L. Welch, Cameron Myhrvold, Pardis C. Sabeti, Hayden C. Metsky
-
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-11 Florian Huber, Marion Arnaud, Brian J. Stevenson, Justine Michaux, Fabrizio Benedetti, Jonathan Thevenet, Sara Bobisse, Johanna Chiffelle, Talita Gehert, Markus Müller, HuiSong Pak, Anne I. Krämer, Emma Ricart Altimiras, Julien Racle, Marie Taillandier-Coindard, Katja Muehlethaler, Aymeric Auger, Damien Saugy, Baptiste Murgues, Abdelkader Benyagoub, David Gfeller, Denarda Dangaj Laniti, Lana Kandalaft
-
A community effort to optimize sequence-based deep learning models of gene regulation Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-11 Abdul Muntakim Rafi, Daria Nogina, Dmitry Penzar, Dohoon Lee, Danyeong Lee, Nayeon Kim, Sangyeup Kim, Dohyeon Kim, Yeojin Shin, Il-Youp Kwak, Georgy Meshcheryakov, Andrey Lando, Arsenii Zinkevich, Byeong-Chan Kim, Juhyun Lee, Taein Kang, Eeshit Dhaval Vaishnav, Payman Yadollahpour, Sun Kim, Jake Albrecht, Aviv Regev, Wuming Gong, Ivan V. Kulakovskiy, Pablo Meyer, Carl G. de Boer
-
Acetaminophen production in the edible, filamentous cyanobacterium Arthrospira platensis Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-11 Jacob M. Hilzinger, Skyler Friedline, Divya Sivanandan, Ya‐Fang Cheng, Shunsuke Yamazaki, Douglas S. Clark, Jeffrey M. Skerker, Adam P. Arkin
Spirulina is the common name for the edible, nonheterocystous, filamentous cyanobacterium Arthrospira platensis that is grown industrially as a food supplement, animal feedstock, and pigment source. Although there are many applications for engineering this organism, until recently no genetic tools or reproducible transformation methods have been published. While recent work showed the production of
-
Online monitoring of methane transfer rates unveils nitrogen fixation dynamics in Methylococcus capsulatus Biotechnol. Bioeng. (IF 3.5) Pub Date : 2024-10-11 Dominik Engel, Maximilian Hoffmann, Udo Kosfeld, Marcel Mann
-
One-step nanoscale expansion microscopy reveals individual protein shapes Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-09 Ali H. Shaib, Abed Alrahman Chouaib, Rajdeep Chowdhury, Jonas Altendorf, Daniel Mihaylov, Chi Zhang, Donatus Krah, Vanessa Imani, Russell K. W. Spencer, Svilen Veselinov Georgiev, Nikolaos Mougios, Mehar Monga, Sofiia Reshetniak, Tiago Mimoso, Han Chen, Parisa Fatehbasharzad, Dagmar Crzan, Kim-Ann Saal, Mohamad Mahdi Alawieh, Nadia Alawar, Janna Eilts, Jinyoung Kang, Alireza Soleimani, Marcus Müller
-
A circularly permuted CasRx platform for efficient, site-specific RNA editing Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-09 Yuanming Wang, Kaiwen Ivy Liu, Mengying Mandy Liu, Kean Hean Ooi, Tram Anh Nguyen, Jiunn En Chee, Shun Xiang Danny Teo, Shan He, Jie Wen Douglas Tay, Seok Yee Teo, Kai Shin Liew, Xiao Yu Ge, Zhi Jian Ng, Hasmik Avagyan, Hao Liu, Zirong Yi, Keziah Chang, Eng Piew Louis Kok, Runjia Chen, Chun En Yau, Jun Wei Koh, Yue Wan, Meng How Tan
-
Rapid species-level metagenome profiling and containment estimation with sylph Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-08 Jim Shaw, Yun William Yu
-
Author Correction: The cost of drug patent expiration date errors Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-08 S. Sean Tu, Dinis Cheian, Sarah Gabriele, Benjamin N. Rome, Aaron S. Kesselheim
Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-024-02298-w, published online 17 July 2024.
-
Engineering a novel pathway for efficient biosynthesis of salicin in Escherichia coli. Metab. Eng. (IF 6.8) Pub Date : 2024-10-09 Jingyan Wang,Qiangjing Zhao,Xin Chen,Yichen Lu,Xinxiao Sun,Qipeng Yuan,Jia Wang,Xiaolin Shen
Salicin is a natural glycoside compound widely used to treat fever, inflammation, and analgesia. Currently, salicin is primarily extracted from willow bark, which is not only cumbersome in terms of extraction and separate steps, but also subject to seasonal and geographic limitations. In this study, a highly efficient biosynthetic pathway for salicin synthesis was designed and constructed in E. coli
-
Improving the growth and intestinal colonization of Escherichia coli Nissle 1917 by strengthening its oligopeptides importation ability. Metab. Eng. (IF 6.8) Pub Date : 2024-10-09 Ruxue Sun,Peijun Yu,Liying Guo,Yufei Huang,Yanhong Nie,Yunpeng Yang
Escherichia coli Nissle 1917 (EcN), the probiotic featured with well-established safety in different host, is emerging as a favored chassis for the construction of engineered probiotics for disease treatment. However, limited by the low intestinal colonization ability of EcN, repeated administration is required to maximize the health benefits of the EcN-derived engineered probiotics. Here, using fecal
-
Advances in optical pooled screening to map spatial complexity Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07 Maurice Kahnwald, Marius Mählen, Koen C. Oost, Prisca Liberali
-
A framework for expanding discovery efforts with compressed phenotypic screens Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07
-
A CRISPR-based method for detecting mRNA in extracellular vesicles Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07
-
AI meets real-world patients Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07
The time has come for biotech companies to embrace machine learning for clinical trials, but they should start with compiling the data. That means grappling with real-world patient records.
-
Scalable, compressed phenotypic screening using pooled perturbations Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07 Nuo Liu, Walaa E. Kattan, Benjamin E. Mead, Conner Kummerlowe, Thomas Cheng, Sarah Ingabire, Jaime H. Cheah, Christian K. Soule, Anita Vrcic, Jane K. McIninch, Sergio Triana, Manuel Guzman, Tyler T. Dao, Joshua M. Peters, Kristen E. Lowder, Lorin Crawford, Ava P. Amini, Paul C. Blainey, William C. Hahn, Brian Cleary, Bryan Bryson, Peter S. Winter, Srivatsan Raghavan, Alex K. Shalek
-
Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07 Jiacheng Gu, Abhishek Iyer, Ben Wesley, Angelo Taglialatela, Giuseppe Leuzzi, Sho Hangai, Aubrianna Decker, Ruoyu Gu, Naomi Klickstein, Yuanlong Shuai, Kristina Jankovic, Lucy Parker-Burns, Yinuo Jin, Jia Yi Zhang, Justin Hong, Xiang Niu, Jonathon A. Costa, Mikael G. Pezet, Jacqueline Chou, Hans-Willem Snoeck, Dan A. Landau, Elham Azizi, Edmond M. Chan, Alberto Ciccia, Jellert T. Gaublomme
-
Amplifying mutational profiling of extracellular vesicle mRNA with SCOPE Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07 Jayeon Song, Mi Hyeon Cho, Hayoung Cho, Younseong Song, Sung Woon Lee, Ho Chul Nam, Tae Ho Yoon, Jong Cheol Shin, Jae-Sang Hong, Yejin Kim, Emil Ekanayake, Jueun Jeon, Dong Gil You, Sung Gap Im, Gyu-Seog Choi, Jun Seok Park, Bob C. Carter, Leonora Balaj, An Na Seo, Miles A. Miller, Soo Yeun Park, Taejoon Kang, Cesar M. Castro, Hakho Lee
-
Multiplexed, image-based pooled screens in primary cells and tissues with PerturbView Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07 Takamasa Kudo, Ana M. Meireles, Reuben Moncada, Yushu Chen, Ping Wu, Joshua Gould, Xiaoyu Hu, Opher Kornfeld, Rajiv Jesudason, Conrad Foo, Burkhard Höckendorf, Hector Corrada Bravo, Jason P. Town, Runmin Wei, Antonio Rios, Vineethkrishna Chandrasekar, Melanie Heinlein, Amy S. Chuong, Shuangyi Cai, Cherry Sakura Lu, Paula Coelho, Monika Mis, Cemre Celen, Noelyn Kljavin, Jian Jiang, David Richmond, Pratiksha
-
Synthetic chest X-ray images from text prompts Nat. Biomed. Eng. (IF 26.8) Pub Date : 2024-10-07 Daniel Truhn, Jakob Nikolas Kather
-
Author Correction: Efficient genetic code expansion without host genome modifications Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07 Alan Costello, Alexander A. Peterson, David L. Lanster, Zhiyi Li, Gavriela D. Carver, Ahmed H. Badran
Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-024-02385-y, published online 11 September 2024.
-
Publisher Correction: Multistate and functional protein design using RoseTTAFold sequence space diffusion Nat. Biotechnol. (IF 33.1) Pub Date : 2024-10-07 Sidney Lyayuga Lisanza, Jacob Merle Gershon, Samuel W. K. Tipps, Jeremiah Nelson Sims, Lucas Arnoldt, Samuel J. Hendel, Miriam K. Simma, Ge Liu, Muna Yase, Hongwei Wu, Claire D. Tharp, Xinting Li, Alex Kang, Evans Brackenbrough, Asim K. Bera, Stacey Gerben, Bruce J. Wittmann, Andrew C. McShan, David Baker
Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-024-02395-w, published online 25 September 2024.